On 7/10/24, Ocular Therapeutix Inc (NASDAQ: OCUL) stock enjoyed a major increase of 11.0%, closing at $7.16. However, this advance was accompanied by below average trading volume at 70% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 7.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, OCUL is expected to continue to be a modest Value Eraser.
Ocular Therapeutix has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Ocular Therapeutix has a very low Appreciation Score of 4 but a very high Power Rating of 95, triggering the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment